Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS44001407HTLV-1ENSG00000185760.18protein_codingKCNQ5NoNo56479Q9NR82
TVIS44032665HTLV-1ENSG00000185760.18protein_codingKCNQ5NoNo56479Q9NR82
TVIS44005586HTLV-1ENSG00000185760.18protein_codingKCNQ5NoNo56479Q9NR82
TVIS44014995HTLV-1ENSG00000185760.18protein_codingKCNQ5NoNo56479Q9NR82
TVIS44009948HTLV-1ENSG00000185760.18protein_codingKCNQ5NoNo56479Q9NR82
TVIS44034591HTLV-1ENSG00000185760.18protein_codingKCNQ5NoNo56479Q9NR82
TVIS44035256HTLV-1ENSG00000185760.18protein_codingKCNQ5NoNo56479Q9NR82
TVIS44035874HTLV-1ENSG00000185760.18protein_codingKCNQ5NoNo56479Q9NR82
TVIS44039097HTLV-1ENSG00000185760.18protein_codingKCNQ5NoNo56479Q9NR82
TCGA Plot Options
Drug Information
GeneKCNQ5
DrugBank IDDB04953
Drug NameEzogabine
Target IDBE0002400
UniProt IDQ9NR82
Regulation Type
PubMed IDs17184917; 12545144; 16713428
CitationsHirano K, Kuratani K, Fujiyoshi M, Tashiro N, Hayashi E, Kinoshita M: Kv7.2-7.5 voltage-gated potassium channel (KCNQ2-5) opener, retigabine, reduces capsaicin-induced visceral pain in mice. Neurosci Lett. 2007 Feb 14;413(2):159-62. Epub 2006 Dec 20.@@Hermann R, Ferron GM, Erb K, Knebel N, Ruus P, Paul J, Richards L, Cnota HP, Troy S: Effects of age and sex on the disposition of retigabine. Clin Pharmacol Ther. 2003 Jan;73(1):61-70.@@Borlak J, Gasparic A, Locher M, Schupke H, Hermann R: N-Glucuronidation of the antiepileptic drug retigabine: results from studies with human volunteers, heterologously expressed human UGTs, human liver, kidney, and liver microsomal membranes of Crigler-Najjar type II. Metabolism. 2006 Jun;55(6):711-21.
GroupsApproved; Investigational
Direct ClassificationPhenylbenzamines
SMILESCCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1
Pathways
PharmGKBPA144997862
ChEMBLCHEMBL41355